Skip to contentC
Chemed Corp
C
CHEChemed Corp Q3 2019 · 10-Q
Revenue$480.61M$480.61M+8.2% vs Q3 2018 Net Income$58.95M$58.95M+15.0% vs Q3 2018 EPS Diluted$3.56$3.56+16.3% vs Q3 2018 Operating Income$64,928,000+5.2% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$117,297,000+21.1% Margins · derivedOperating margin13.5%−0.4 pt vs Q3 2018
Net margin12.3%+0.7 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 4, 2019 · 35 d after period end